Role Summary
The Director, US Market Access Early Pipeline supports market access strategy across the pipeline, informing indication choices and key clinical trial design elements. The role works across US and Global teams to develop disease-area strategies that optimize access and maximize overall product value, with remote work options in the U.S. and up to 10% travel as defined by the hiring manager.
Responsibilities
- Providing US Market Access forecasting assumptions, including pricing (gross and net), anticipated payer coverage, and implications of coverage quality on physician demand and patient Rx fulfillment for assets and indications
- Developing strategies to optimize payer coverage, patient affordability, and sales revenue for assets across multiple indications and therapeutic areas
- Conducting payer market research, analyzing secondary data, and incorporating internal experience to inform assumptions and recommendations
- Assessing clinical trial designs for market access risks or opportunities to optimize coverage and patient access (e.g., formulation, dosing, outcomes, data to support positive coverage, choice of comparator, potential cost-offset data)
- Collaborating across US and Global teams to create disease-area assessments for proof-of-concept assets and define what it takes to be commercially successful in different disease areas
Qualifications
- Minimum of 7 years of pharmaceutical experience in Market Access, Marketing, Managed Care Finance, Insights & Analytics or Business Development
- Awareness and understanding of US healthcare dynamics and drivers of pharmaceutical value
- Strong interpersonal, communication, and influencing skills with ability to collaborate across a matrix organization
- Ability to analyze complex business issues and connect commercial, financial, and clinical perspectives to develop enhanced value propositions
Education
- Bachelorβs degree required; MBA, Health Policy or equivalent preferred